Company Information

CIN
Status
Date of Incorporation
23 April 2001
State / ROC
Ahmedabad / ROC Ahmedabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
144,000
Authorised Capital
200,000

Directors

Chandulal Arjanbhai Patel
Chandulal Arjanbhai Patel
Director
over 24 years ago
Madhusudan Arjanbhai Patel
Madhusudan Arjanbhai Patel
Director
over 24 years ago

Past Directors

Arjanbhai Virjibhai Patel
Arjanbhai Virjibhai Patel
Director
over 24 years ago

Registered Trademarks

Limak Limak Remedies

[Class : 5] Pharmaceutical & Medicinal Preparation Included In Class 5.

Documents

Form DPT-3-16122020_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-15122020
Directors report as per section 134(3)-15122020
List of share holders, debenture holders;-15122020
Form AOC-4-15122020_signed
Form MGT-7-15122020
Form DPT-3-31012020-signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-12102019
Directors report as per section 134(3)-12102019
List of share holders, debenture holders;-12102019
Form MGT-7-12102019_signed
Form AOC-4-12102019_signed
Form ADT-1-11102019_signed
Copy of written consent given by auditor-11102019
-11102019
Copy of resolution passed by the company-11102019
Form DPT-3-26072019
Auditor?s certificate-26072019
Evidence of cessation;-11042019
Form DIR-12-11042019_signed
Optional Attachment-(1)-11042019
Form MGT-7-27092018_signed
List of share holders, debenture holders;-12092018
Directors report as per section 134(3)-12092018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-12092018
Form AOC-4-12092018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-19102017
List of share holders, debenture holders;-19102017
Directors report as per section 134(3)-19102017
Form AOC-4-19102017_signed